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Molecular epidemiologyCarbapenem resistance among Acinetobacter baumannii strains isolated from clinical settings in Brazil has
increased dramatically in the last 10 years due to the emergence and dissemination of OXA-type carba-
penemase encoding genes. This study aimed to characterize the presence of carbapenem-hydrolyzing
class D b-lactamases (CHDL)-encoding genes and clonal complexes playing a major role in the dissemi-
nation of OXA-carbapenemase-producing A. baumannii in Southeast Brazil.
A total of 74 A. baumannii strains isolated from patients admitted to 4 hospitals in Southeast Brazil
were analyzed. Molecular characterization of strains revealed that 67 strains carried blaOXA-23 (72%),
blaOXA-143 (25%) or both genes (3%). PFGE analysis identiﬁed 12 PFGE clusters, grouping 26 pulsotypes.
Two PFGE clusters were predominant, comprising more than 66% of OXA-producing A. baumannii isolates.
Among 23 representative strains characterized by MLST-UO (Multilocus Sequence Typing Scheme – Uni-
versity of Oxford, http://pubmlst.org/abaumannii/), 14 different STs were identiﬁed, of which six were
conﬁrmed as novel sequence types (designated as STs 402–407). Most of these isolates belonged to clonal
complexes CC104,CC109 or CC113, whereas three STs were singletons (ST339, 403 and 407).
In conclusion, the presence of blaOXA-23- and blaOXA-143-like genes was not related to speciﬁc ST/CC, sug-
gesting that the dissemination of OXA-carbapenemase-encoding genes may involve different STs, in
which the spread of OXA-23-like is most likely due to mobile elements (i.e., plasmids). In this regard,
CC104, CC109 and CC113 played a major role as predominant CDHL-carrying clones, instead of CC92,
which was not identiﬁed.
 2013 Elsevier B.V. All rights reserved.1. Introduction
Among the species of the Acinetobacter genus, Acinetobacter
baumannii is the most clinically relevant, as it is frequently isolated
from hospitalized patients, especially causing outbreaks in inten-
sive care units (ICUs) (Peleg et al., 2008). Despite of its low patho-
genicity, A. baumannii is able to survive in adverse environments
for long periods of time, becoming one of the most important
opportunistic pathogens of nosocomial infections such as ventila-
tor-associated pneumonia, bloodstream infections, postoperativeinfections, meningitis and urinary tract infection (Peleg et al.,
2008). Invasive procedures, such as central venous catheter and
ventilator use, recent major surgery, prior antimicrobial treatment,
prolonged hospitalization and prior A. baumannii colonization have
been identiﬁed as risk factors for facilitating A. baumannii
infections (Jang et al., 2009). Furthermore, A. baumannii has
emerged as an important pathogen in military treatment facilities
(O’Shea, 2012).
In the last years, carbapenem resistance has been continuously
reported among A. baumannii isolates, causing major therapeutic
problems worldwide. Although efﬂux pumps over expression and
porin loss appears to contribute to carbapenem resistance, the
production of carbapenem-hydrolyzing class D b-lactamases
(CHDL) is being increasingly reported globally, constituting the
main mechanism of carbapenem resistance among Acinetobacter
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Currently, there are six subclasses of CDHL associated with A. bau-
mannii: intrinsic chromosomal OXA-51-like enzymes and acquired
OXA-23-, OXA-24-, OXA-58-, OXA-143- and OXA-235-like. In con-
trast with other subclasses, the carbapenemase activity of natu-
rally occurring OXA-51-like enzymes is associated with ISAbaI,
agenetic element that contains a strong promoter (Walther-Ras-
mussen and Høiby, 2006). Whilst the acquired enzymes OXA-23-,
OXA-24-, OXA-51- and OXA-58-like have been disseminated
worldwide, OXA-143-like has been found in A. baumannii strains
from Brazil and OXA-235-like enzymes were recently identiﬁed
in ten isolates from USA and Mexico (Walther-Rasmussen and
Høiby, 2006; Higgins et al., 2009, 2013).
Despite the fact that the role of OXA enzymes is well estab-
lished, molecular epidemiology studies of CHDL-producing A. bau-
mannii are extremely useful to rapidly identify the emergence and
dissemination of international MDR A. baumannii clones and to
analyze their ancestor and evolutionary relationship (Irfan et al.,
2011).
This study aimed to investigate the distribution of carbapenem-
ase- and extended-spectrum b-lactamase-encoding genes among
carbapenem-resistant A. baumannii isolates recovered between
2008 and 2010, from 4 hospitals in Southeast Brazil, determining
their genetic relationship by PFGE analysis. In addition, MLST
was used to verify the lineage of isolates with different susceptibil-
ity patterns and pulsotypes.2. Materials and methods
2.1. Bacterial isolates
Between August 2008 and January 2010, 74 non-repetitive clin-
ical A. baumannii isolates recovered from different clinical samples
(intravenous catheter, tracheal secretion, blood, urine, peritoneal
ﬂuid, wound, spit) were collected in four hospitals in the Southeast
region of Brazil. Whilst sixty-seven isolates were characterized as
resistant to carbapenems (CRAB), seven carbapenem-susceptible
A. baumannii (CSAB) isolates were included in the study for com-
parative evaluation. A. baumannii isolates were identiﬁed by means
of the Vitek 2 automated instrument ID system (Vitek AMS; bio-
Merieux Vitek Systems, Hazelwood, MO, USA), conventional bio-
chemical tests (Vaneechoutte et al., 2011) and by detection of
the blaOXA-51-type gene (Turton et al., 2006). Conﬁrmation was per-
formed by PCR and sequencing of internal and ﬂanking regions of
the rpoB gene (La Scola et al., 2006).
2.2. Antimicrobial susceptibility test
Antimicrobial susceptibility proﬁles were determined by disk
diffusion according to CLSI guidelines (CLSI, 2012a,b). The antibiot-
ics tested were gentamicin, tobramycin, amikacin, ticarcillin–cla-
vulanate, piperacillin–tazobactam, meropenem, imipenem,
ceftazidime, cefotaxime, cefepime, ciproﬂoxacin, levoﬂoxacin,
colistin, ampicillin–sulbactam, doxycicline, minocycline, tigecy-
cline and polymyxin B. A breakpoint zone diameter of P16/
612 mmwas used to deﬁne susceptibility/resistance to tigecycline
(Jones et al., 2007). The polymyxin resistance phenotype was con-
ﬁrmed by Etest (bioMérieux, France).
2.3. Molecular detection of beta-lactamases-encoding genes
Genomic DNA was extracted as described elsewhere (Pitcher
et al., 1989) and multiplex polymerase chain reactions were per-
formed to investigate the presence of CHDL-encoding genes
(blaOXA-23-, blaOXA-24-, blaOXA-51-, blaOXA-58- and blaOXA-143-like)using speciﬁc primers, as previously described (Woodford et al.,
2006; Higgins et al., 2010). Additional screening of class B and A
carbapenemase- and extended-spectrum beta-lactamase (ESBL)-
encoding genes was performed by conventional PCR. Speciﬁc prim-
ers, described elsewhere (Saladin et al., 2002; Pitout et al., 2004;
Rasheed et al., 1997), are quoted in Table 1. Ampliﬁcations were
carried out in a total volume of 25 lL, with 60 ng of template
DNA, 24 pmol of primers (Invitrogen, Carlsbad, California), 5 lL
10 buffer, 2 mmol/L MgSO4 (Invitrogen), 0.5 lmol of each deoxy-
nucleoside triphosphate (Eppendorf, Westbury, New York), and
0.625 U Taq High Fidelity DNA polymerase (Invitrogen). PCR reac-
tions were performed in a Mastercycler Gradient (Eppendorf),
using as cycling program an initial cycle of 5 min at 95 C; followed
by 30 cycles of 1 min at 95 C, 1 min at annealing temperature (Ta-
ble 1), 1 min at 72 C; and a ﬁnal extension cycle of 10 min at 72 C.
The PCR products were analyzed under 1% agarose gel electropho-
resis and visualized by UV light after staining the gel with ethidium
bromide.2.4. Pulsed-ﬁeld gel electrophoresis
Genomic DNA macrorestriction proﬁles of A. baumannii strains
were determined by pulsed-ﬁeld gel electrophoresis (PFGE) after
DNA extraction and digestion using SmaI (Invitrogen, Paisley,
UK), as described elsewhere (Tenover et al., 1995). DNA fragments
were separated by electrophoresis in 1% ultra-pure agarose gels
(Invitrogen) and 0.5 Tris–borate–EDTA buffer, at 14 C, using
the CHEFF III apparatus (Bio-Rad Laboratories, Hercules, California)
at 6 V/cm2 with switch times ranging from 5 s to 20 s at an angle of
120, for 19 h. A standard molecular weight ladder (Lambda Ladder
50–1000 kb PFG Marker; New England Biolabs) was included twice
in each gel to compare the ﬁngerprints on different gels. Processed
gels were stained with ethidiumbromide, and DNA banding pat-
tern images were documented after transillumination with UV
light in AlphaImage gel documentation system (Alpha Innotech,
San Leandro, CA).
Bionumerics 5.01 software (Applied Maths, Ghent, Belgium)
was used for dendrogram construction by the UPGMA (Un-
weighted Pair Group Method with Arithmetic Mean) method,
based on Dice’s similarity coefﬁcient. Pulsotypes were deﬁned as
per the criteria described by Tenover (Tenover et al., 1995),
whereas isolates were considered to belong to the same PFGE clus-
ter if their Dice similarity index was P84%.2.5. Multi locus sequence typing (MLST)
Twenty-three selected A. baumannii isolates showing different
resistance patterns (phenotype/genotype) and representative of
the major PFGE clusterss were subjected to MLST analysis (Bartual
et al., 2005), using speciﬁc primers and conditions described in the
A. baumannii MLST database of the University of Oxford (http://
pubmlst.org/abaumannii). The amplicons were puriﬁed using
GFX PCR (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK)
and sequenced using primers (forward and reverse) described in
the database website (http://pubmlst.org/abaumannii), with the
MegaBace™ 1000 DNA Sequencing System (GE Healthcare). The
sequences obtained were analyzedusing the ChromasPro software
version 1.5 (Technelysium Pty. Ltd., South Brisbane, Australia).
Sequence types (STs) were assigned using the MLST database
and new MLST alleles and STs were assigned by the curators of
the database. Finally, molecular epidemiology was established
using the eBURST software (http://eburst.mlst.net/).
Table 1
Primers used in the study for PCR ampliﬁcation of resistance genes.
Primer Sequence (50–30) Annealing Temperature (C) ampliﬁed fragment/length (pb) Reference
OXA-51-F TAATGCTTTGATCGGCCTTG 52 blaOXA-51-like/353 Woodford et al., 2006
OXA-51-R TGGATTGCACTTCATCTTGG 52 Woodford et al., 2006
OXA-23-F GATCGGATTGGAGAACCAGA 52 blaOXA-23-like/501 Woodford et al., 2006
OXA-23-R ATTTCTGACCGCATTTCCAT 52 Woodford et al., 2006
OXA-40-F GGTTAGTTGGCCCCCTTAAA 52 blaOXA-40-like/246 Woodford et al., 2006
OXA-40-R AGTTGAGCGAAAAGGGGATT 52 Woodford et al., 2006
OXA-58-F AAGTATTGGGGCTTGTGCTG 52 blaOXA-58-like/599 Woodford et al., 2006
OXA-58-R CCCCTCTGCGCTCTACATAC 52 Woodford et al., 2006
OXA-143-F TGGCACTTTCAGCAGTTCCT 52 blaOXA-143/149 Higgins et al., 2010
OXA-143-R TAATCTTGAGGGGGCCAACC 52 Higgins et al., 2010
IMP-P1 CGAGAAGCTTGAAGAAGGTGTT 60 blaIMP-2,-8,-13,-19,-20,-24/512 This work
IMP-P2 CGGACTTTGGCCAAGCTTCTA 60 This work
IMP-P3 GAAGTTAACGGGTGGGGCGTT 60 blaIMP-1,-3,-4,-6,-10/578 This work
IMP-P4 CCTTTAACCGCCTGCTCTAATG 60 This work
IMP-P5 GACAGTACGGSTGGAATAGAG 59 blaIMP-12, -14, -18/407 This work
IMP-P6 CCTTTAACAGCCTGCTCCCA 59 This work
IMP-P7 GTAGCATTACTGCCGCAGGA 59 blaIMP-11,-16,-21,-22/643 This work
IMP-P8 GTAAGCTTCAAGAGCGACGCA 59 This work
IMP-P9 CCTAAACACGGCTTGGTGGTT 59 blaIMP-5,-7,-9,-15/349 This work
IMP-P10 GCCAAACCACTACGTTATCTGG 59 This work
VIM-P1 GTTATTGGTCTATTTGACCGCG 58 blaVIM-2,-3,-6,-8,-9,-10,-11,-18/781 This work
VIM-P2 CTACTCAACGACTGAGCGATTT 58 This work
VIM-P3 GGTCTACATGACCGCGTCTGT 61 blaVIM-1,-4 -5,-14/775 This work
VIM-P4 CTACTCGGCGACTGAGCGATT 61 This work
VIM-P5 CGATGGYGTTTGGTCGCATAT 58 blaVIM-7,-12,-13/390 This work
VIM-P6 GAATGCGCAGCACCAGGATA 58 This work
SPM-F GAGAGCCCTGCTTGGATTCAT 59 blaSPM-1 / 811 This work
SPM-R CAGTCTCATTTCGCCAACGG 59 This work
KPC-F GTATCGCCGTCTAGTTCTGCTG 61 blaKPC / 871 This work
KPC-R GTTGACGCCCAATCCCTCGA 61 This work
MA1 SCSATGTGCAGYACCAGTAA 57 blaCTX-M-1,-2,-9 groups/544 Saladin et al., 2002
MA2 CCGCRATATGRTTGGTGGTG 57 Saladin et al., 2002
CTXM1 f3 GACGATGTCACTGGCTGAGC 53 blaCTX-M-1 group / 499 Pitout et al., 2004
CTXM1 r2 AGCCGCCGACGCTAATACA 53 Pitout et al., 2004
M2f ATGATGACTCAGAGCATTCG 55 blaCTX-M-2 group/866 Saladin et al., 2002
M2r TGGGTTACGATTTTCGCCGC 55 Saladin et al., 2002
M9f ATGGTGACAAAGAGAGTGCA 55 blaCTX-M-9 group/870 Saladin et al., 2002
M9r CCCTTCGGCGATGATTCTC 55 Saladin et al., 2002
M8f CTGGAGAAAAGCAGCGGGGG 51 blaCTX-M-8,-25 groups/581 This work
M8r ACCCACGATGTGGGTAGCCC 51 This work
TEM f ATGAGTATTCAACATTTCCG 58 blaTEM Rasheed et al., 1997
TEM r CTGACAGTTACCAATGCTTA 58 Rasheed et al., 1997
SHV f GGGTTATTCTTATTTGTCGC 56 blaSHV Rasheed et al., 1997
SHV r TTAGCGTTGCCAGTGCTC 56 Rasheed et al., 1997
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All 67 CRAB isolates displayed resistance to cefotaxime, ceftaz-
idime, cefepime, piperacillin–tazobactam and ciproﬂoxacin. Fur-
thermore, non-susceptibility to ampicillin–sulbactam, gentamicin
and levoﬂoxacin occurred in 54%, 60%, and 84% of isolates, respec-
tively. On one hand, CRAB isolates showed high susceptibility to
colistin (100%), doxycicline (100%), polymyxin (90%) and tigecy-
cline (90%). On the other hand, all 7 CSAB isolates were resistant
to cefotaxime, ceftazidime, cefepime, ciproﬂoxacin, of which four
isolates displayed non-susceptibility to gentamicin and levoﬂoxa-
cin, and other two A. baumannii isolates were non-susceptible to
tigecycline and piperacillin–tazobactam.
Although genes encoding OXA-51 were detected in all CRAB/
CSAB isolates included in the study, acquired CHDL-encoding genes
were only identiﬁed among CRAB isolates. In this regard, the pres-
ence of blaOXA-23- and blaOXA-143-like genes was conﬁrmed in 71.6%
and 25.4% of CRAB, respectively, whereas both genes were identi-
ﬁed in 3% of CRAB isolates. Genes encoding for class A or B carba-
penemases, or ESBLs, were not found.
Based on Tenover’s criteria (Tenover et al., 1995), PFGE analysis,
the A. baumannii isolates were classiﬁed into 26 pulsotypes (named
A–Z, in Fig. 1) and these subtypes were grouped into 12 different
PFGE clusters (named I–XII, in Fig. 1). Two PFGE clusters (I andII) were predominant, grouping 30 and 19 isolates, respectively,
whereas the other ten PFGE clusters contained up to 8 A. baumannii
isolates each (Fig. 1). Clusters I and II grouped more 66% of the
OXA-producing isolates and pulsotype A was predominant (23 iso-
lates) (Fig. 1). The majority of OXA-23-like producing A. baumannii
strains, belonging to pulsotype A, were recovered from the hospital
JF, whereas OXA-143 positive strains, belonging to pulsotypes E, J,
Q and T, were more prevalent in the hospital SP-I. Five out of the
seven CSAB isolates were grouped into PFGE clusters with CRAB
isolates (3 into PFGE cluster I, and 2 into PFGE cluster III). The other
2 CSBA isolates were unique in their PFGE clusters (IX and XII)
(Fig. 1).
MLST analysis of the 23 A. baumannii isolates with different
resistance patterns and representative of the major PFGE clusters
revealed fourteen different STs including the previously described
STs 99, 103, 108, 109, 113, 227, 236, 339; and the novel STs 402,
403, 404, 405, 406 and 407 (Fig. 1). Subsequent eBURST analysis
showed that typed isolates from the representative PFGE clusters
belonged to clonal complexes CC104 (ST103, 236, 402 and 404),
CC109 (ST108, 109, 405 and 406) and CC113 (ST99, 113 and
227). Three STs described in this study were singletons (ST339,
403 and 407) (Fig. 2). Among the four CSAB isolates investigated
by MLST, two were typed as ST99 (CC113), one as ST108 (CC109)
and one as ST109 (CC109).
Fig. 1. Dendrogram of genomic similarity representative of PFGE proﬁles presented by isolates of Acinetobacter baumannii using the UPGMA (Unweighted Pair Group Method
with Arithmetic) method based on Dice’s similarity. Dotted lines deﬁne the cutoff for clonal groups (84%) and for pulsotypes (92%). SG represents singleton STs. Hospitals (JF,
SP-I, SP-II and SP-III) are indicated as following the strain identiﬁcation.
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CC113 were mainly located in cluster I. In contrast, isolates located
in PFGE cluster II belonged to CC104. Isolates grouped in CC109
(International Clone I) showed pulsotypes located in four differentPFGE clusters (III, VI, VII and XI). These results showed that PFGE
typing was complementary to MLST to deﬁne isolates belonging
to the international clone I. Even though OXA-23-like and OXA-
143-like producing isolates were grouped in the three clonal
Fig. 2. eBURST diagram showing the analyzed sequence types (STs) of the Brazilian strains and all STs assigned for the entire public A. baumannii multilocus sequence type
database (http://pubmlst.org/abaumannii/). Each ST is represented by a dot in proportional size to the number of A. baumannii involved, considering all strains in the
database. STs related to A. baumannii strains from Brazil are indicated by arrows, of which white arrows indicate the STs related to the strains of this study. The main clonal
complexes (CCs) are named next to them.
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boring encoding genes of each enzyme in several cases.
Currently, the MLST database (http://pubmlst.org/abaumannii)
includes 38 different STs of A. baumannii isolated from Brazil
(Fig. 2). According to eBURST analysis, most CRAB strains isolated
in the Southeast region of Brazil comprised isolates of different
STs, clonally related and grouped into the clonal complexes
CC104, CC109 and CC113, which included mainly single-locus vari-
ants (SLVs) or less commonly, double- (DLVs), or triple-locus vari-
ants (TLVs) (Fig. 2). Among CRAB isolates carrying acquired
CHDL-encoding genes, three strains were characterized as single-
tons and six novel STs were identiﬁed.4. Discussion
Carbapenem-resistant non-fermenter bacilli (mainly, Pseudo-
monas aeruginosa and A. baumannii) have become increasingly iso-
lated in Brazil. In this regard, resistance to carbapenem among A.
baumannii isolates has been mostly related to the production of
CHDL (Dalla-Costa et al., 2003; Antonio et al., 2011; Mostachio
et al., 2012; Martins et al., 2012), which was conﬁrmed in this
study, as blaOXA-23- and blaOXA-143-like were the most prevalent
CHDL-encoding genes identiﬁed.
Worldwide dissemination of the blaOXA-23 carbapenemase gene
has been associated with speciﬁc clones, mainly the international
CC92, which is the largest and most widespread clonal complex
in the A. baumannii MLST database, currently comprising 207
strains and 46 different STs. OXA-23-producing A. baumannii
strains belonging to CC92 have been identiﬁed in many countries
around the world, including Australia, United States of America
(USA), China, Italy, France, Tahiti, Vietnam, New Caledonia, Thai-
land and South Africa (Adams-Haduch et al., 2011; Ansaldi et al.,
2011; Fu et al., 2010; Lee et al., 2012; Nigro and Hall, 2012; Mug-
nier et al., 2010; Runnegar et al., 2010). Moreover, A. baumannii iso-
lates carryingISAbaI-blaOXA-51-, blaOXA-58-, or blaOXA-40-like genes,belonging to the CC92, have been reported in Japan, Italy, and
USA, respectively (Adams-Haduch et al., 2011; Ansaldi et al.,
2011; Endo et al., 2012).
In Latin American countries, MLST allelic proﬁles have not been
related to the worldwide-predominant ST92/OXA-23 A. baumannii
(Grosso et al., 2011; Martins et al., 2013; Stietz et al., 2013) and, in-
deed, this phenomenon was also observed in this study, in which
none of the twenty-three representative strains analyzed by MLST
belonged to CC92. In contrast, CRAB carrying blaOXA-23- and/or
blaOXA-143-like genes belonged mainly to CC104, CC109 and
CC113. Since the acquired CHDL-encoding genes were not related
to speciﬁc ST, it suggests that dissemination of these genes in Brazil
should be associated with plasmid-mediated mobilization. This
hypothesis is supported by Mugnier and co-workers (2010) which
showed CRAB isolates not belonging to CC92 harboredblaOXA-23
gene located in similar plasmids (Mugnier et al., 2010).
In this respect, most OXA-23 producing A. baumannii strains iso-
lated in Latin America have been commonly reported as belonging
to CC113 (Grosso et al., 2011; Martins et al., 2013; Ramírez et al.,
2013; Stietz et al., 2013). On the other hand, although OXA-23-pro-
ducing A. baumannii isolates belonging to the international CC109
have been previously identiﬁed in Brazil, only the presence of
ST231 has been reported so far (Martins et al., 2012). Thus, this
study shows that other STs of A. baumannii, belonging to the
CC109, have acquired CHDL-encoding genes, including isolates
conﬁrmed as novel sequence types, designated as STs 405 and
406, which have not been described elsewhere. Curiously, CRAB
isolates of ST405 and ST406 harbored the novelblaOXA-143 gene,
whereas the one ST109 strain harbored both blaOXA-23- and
blaOXA-143-like genes. Furthermore, two ST109 strains carried the
blaOXA-23-like gene, an association that has been previously identi-
ﬁed in CRAB strains isolated in Europe, Africa and Persian Gulf
countries (Ansaldi et al., 2011; Mugnier et al., 2010).
Regarding CC104, this clonal complex currently consists of eight
STs comprising 24 strains, which have been mainly identiﬁed in
Brazil and Argentina, and sporadically in Europe (Norway, Portugal,
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et al., 2012; Martins et al., 2013; Ramírez et al., 2013). In line with
previous reports, our results conﬁrm the predominance of this clo-
nal complex among CRAB isolates from Southeast Brazil (Martins
et al., 2013), suggesting local endemicity associated with the acqui-
sition of CHDL-encoding genes. Indeed, unlike CC109 and CC113,
CC104 comprised only CRAB isolates, carrying blaOXA-23- or
blaOXA-143-like genes of four different STs, of which two are re-
ported as novel STs. In this regard, isolates of the new STs
402and 404 carried blaOXA-23-like genes, whereas genes encoding
OXA-143-like enzymes were found in CRAB isolates of ST236 and
ST103.
Finally, this study conﬁrms PFGE and MLST to be complemen-
tary tools in clonality studies. In this regard, it was possible to ob-
serve a good correlation between these two techniques, since most
A. baumannii strains grouped into PFGE clusters I, II and III, were
correlated to the MLST-deﬁned CC113, CC104 and CC109,
respectively.
5. Conclusion
In conclusion, the present study provides new data regarding
the low frequency of the international CC92 (clone II) among carb-
apenem non-susceptible A. baumannii isolates in South America,
highlighting the importance of the clonal complexes CC104,
CC109 and CC113 in Southeast Brazil. In addition, the presence of
blaOXA-23- and blaOXA-143-like genes was not related to speciﬁc ST/
CC, suggesting that the spread of OXA-23-like is most likely due
to mobile elements (i.e., plasmids). Consequently, the great adap-
tive potential of A. baumannii strains, hereby evidenced by the
large amount of new STs found, may be one of the major factors
contributing to the dissemination of OXA-producing A. baumannii
in Brazil.
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